Stephen Clarke
Active 1979–2024
- 146
- Papers
- 24,638
- Citations
- 81
- h-index
- 139
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine70.1%
- Biochemistry, Genetics and Molecular Biology17.6%
- Immunology and Microbiology3.3%
- Pharmacology, Toxicology and Pharmaceutics1.5%
- Materials Science1.2%
- Neuroscience1%
- Other5.3%
Topics
- Inflammatory Biomarkers in Disease Prognosis6.3%
- Cancer Immunotherapy and Biomarkers3.3%
- Colorectal Cancer Treatments and Studies3.3%
- Colorectal Cancer Surgical Treatments2%
- Lung Cancer Treatments and Mutations2%
- Cancer survivorship and care1.8%
- Other81.3%
Coauthors
- Nick Pavlakis33
- Steven Kao15
- Philip Beale13
- Connie I. Diakos12
- Kellie A. Charles12
- Anthony J. Gill11
- Byeongsang Oh11
- Malinda Itchins10
- Mark P. Molloy10
- Michael Boyer10
- Phyllis Butow10
- Janette L. Vardy9
- Glen Reid8
- David S. Rosenthal7
- George Hruby7
- Graham Robertson7
- Jaswinder S. Samra7
- Laurent P. Rivory7
- Leonard B. Saltz7
- Martin R. Stockler7
- Andrew Kneebone6
- Christopher Liddle6
- David Chan6
- Eduardo Díaz‐Rubio6
All papers
- Cancer-related inflammation and treatment effectiveness
Authors: Connie I. Diakos, Kellie A. Charles, Donald C. McMillan, Stephen Clarke - The Lancet Oncology 2014 cited by 2,187
- Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
Authors: Nico van Zandwijk, Nick Pavlakis, Steven Kao, Anthony Linton, Michael Boyer, Stephen Clarke, Y. Wendy Huynh, Agata Chrzanowska, Michael Fulham, Dale L. Bailey, Wendy A. Cooper, Leonard Kritharides, Lloyd J Ridley, Scott Pattison, Jennifer A. MacDiarmid, Himanshu Brahmbhatt, Glen Reid - The Lancet Oncology 2017 cited by 709
- The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
Authors: Graeme J.K. Guthrie, Kellie A. Charles, Campbell S.D. Roxburgh, Paul G. Horgan, Donald C. McMillan, Stephen Clarke - Critical Reviews in Oncology/Hematology 2013 cited by 1,539
- Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial
Authors: Bob T. Li, Ronglai Shen, Darren J. Buonocore, Zachary T. Olah, Ai Ni, Michelle S. Ginsberg, Gary A. Ulaner, Michael Offin, Daniel Feldman, Todd Hembrough, Fabiola Cecchi, Sarit Schwartz, Nick Pavlakis, Stephen Clarke, Helen Won, Edyta B. Brzostowski, Gregory J. Riely, David B. Solit, David M. Hyman, Alexander Drilon, Charles M. Rudin, Michael F. Berger, José Baselga, Maurizio Scaltriti, Maria E. Arcila, Mark G. Kris - Journal of Clinical Oncology 2018 cited by 559
- Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
Authors: Justin Jee, Emily S. Lebow, Randy Yeh, Jeeban P. Das, Azadeh Namakydoust, Paul K. Paik, Jamie E. Chaft, Gowtham Jayakumaran, A. Rose Brannon, Ryma Benayed, Ahmet Zehir, Mark T.A. Donoghue, Nikolaus Schultz, Debyani Chakravarty, Ritika Kundra, Ramyasree Madupuri, Yonina R. Murciano‐Goroff, Hai‐Yan Tu, Chong‐Rui Xu, Andrés Martinez, Clare Wilhelm, Jesse Galle, Bobby Daly, Helena A. Yu, Michael Offin, Matthew D. Hellmann, Piro Lito, Kathryn C. Arbour, Marjorie G. Zauderer, Mark G. Kris, Kenneth Ng, Juliana Eng, Isabel R. Preeshagul, W. Victoria Lai, John J. Fiore, Afsheen N. Iqbal, Daniela Molena, Gaetano Rocco, Bernard J. Park, Lee P. Lim, Mark Junjie Li, Candace Tong-Li, Madhawa De Silva, David Chan, Connie I. Diakos, Malinda Itchins, Stephen Clarke, Nick Pavlakis, Adrian V. Lee, Natasha Rekhtman, Jason C. Chang, William D. Travis, Gregory J. Riely, David B. Solit, Mithat Gönen, Valerie W. Rusch, Andreas Rimner, Daniel R. Gomez, Alexander Drilon, Howard I. Scher, Sohrab P. Shah, Michael F. Berger, Maria E. Arcila, Marc Ladanyi, Ross L. Levine, Ronglai Shen, Pedram Razavi, Jorge S. Reis‐Filho, David R. Jones, Charles M. Rudin, James M. Isbell, Bob T. Li - Nature Medicine 2022 cited by 185
- First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors
Authors: Johanna C. Bendell, Patricia LoRusso, Michael J. Overman, Anne M. Noonan, Dong‐Wan Kim, John H. Strickler, Sang‐We Kim, Stephen Clarke, Thomas J. George, Peter Grimison, Minal Barve, Manik Amin, Jayesh Desai, Trisha M. Wise‐Draper, Steven Eck, Yu Jiang, Anis A. Khan, Yuling Wu, Philip Martin, Zachary A. Cooper, Nairouz Elgeioushi, Nancy K. Mueller, Rakesh Kumar, Sandip Pravin Patel - Cancer Immunology Immunotherapy 2023 cited by 109
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
Authors: Leonard B. Saltz, Stephen Clarke, Eduardo Díaz‐Rubio, Werner Scheithauer, Arié Figer, Ralph Wong, Sheryl Koski, Mikhail Lichinitser, Tsai‐Shen Yang, Fernando Rivera, Félix Couture, Florin Sirzén, Jim Cassidy - Journal of Clinical Oncology 2008 cited by 2,963
- Clinical Development of TargomiRs, a miRNA Mimic-Based Treatment for Patients with Recurrent Thoracic Cancer
Authors: Glen Reid, Steven Kao, Nick Pavlakis, Himanshu Brahmbhatt, Jennifer A. MacDiarmid, Stephen Clarke, Michael Boyer, Nico van Zandwijk - Epigenomics 2016 cited by 230
- Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance
Authors: David LH Chan, Nick Pavlakis, Geoffrey Schembri, Elizabeth J. Bernard, Edward Hsiao, Aimee R. Hayes, T. Barnes, Connie I. Diakos, Mustafa Khasraw, Jaswinder S. Samra, Enid M. Eslick, Paul Roach, Alexander Engel, Stephen Clarke, Dale L. Bailey - Theranostics 2017 cited by 286
- Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial
Authors: Peter Grimison, Antony Mersiades, Adrienne Kirby, Nicholas Lintzeris, Rachael L. Morton, Paul Haber, Ian Olver, Alexandra Walsh, Iain S. McGregor, Y. Cheung, Annette Tognela, Carmel Hahn, Karen Briscoe, Morteza Aghmesheh, Peter Fox, Ehtesham Abdi, Stephen Clarke, Stephen Della‐Fiorentina, Jenny Shannon, Craig Gedye, Stephen Begbie, John Simes, Martin R. Stockler - Annals of Oncology 2020 cited by 153
- The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer
Authors: Joseph Chan, David Chan, Connie I. Diakos, Alexander Engel, Nick Pavlakis, Anthony J. Gill, Stephen Clarke - Annals of Surgery 2016 cited by 302
- Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
Authors: Quisette P. Janssen, Stefan Buettner, Mustafa Suker, Berend R. Beumer, Pietro Addeo, Philippe Bachellier, Nathan Bahary, Tanios Bekaii‐Saab, Maria Antonietta Bali, Marc G. Besselink, Brian A. Boone, Ian Chau, Stephen Clarke, Mary Dillhoff, Bassel F. El‐Rayes, Jessica M. Frakes, Derek Grose, Peter J. Hosein, Nigel B. Jamieson, Ammar A. Javed, Khurum Khan, Kyu-pyo Kim, Song Cheol Kim, Sunhee S. Kim, Andrew H. Ko, Jill Lacy, Georgios Antonios Margonis, Martin D. McCarter, Colin J. McKay, Eric A. Mellon, Sing Yu Moorcraft, Ken‐ichi Okada, Alessandro Paniccia, Parag J. Parikh, Niek A. Peters, Hans Rabl, Jaswinder S. Samra, Christoph Tinchon, Geertjan van Tienhoven, Eran van Veldhuisen, Andrea Wang‐Gillam, Matthew J. Weiss, Johanna W. Wilmink, Hiroki Yamaue, Marjolein Y.V. Homs, Casper H.J. van Eijck, Matthew H. G. Katz, Bas Groot Koerkamp - JNCI Journal of the National Cancer Institute 2019 cited by 295
- Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial
Authors: Aimery de Gramont, Eric Van Cutsem, Hans‐Joachim Schmoll, Josep Tabernero, Stephen Clarke, Malcolm J. Moore, David Cunningham, Thomas H. Cartwright, J. Randolph Hecht, Fernando Rivera, Seock‐Ah Im, G. Bodoky, Ramón Salazar, Frédérique Maindrault-Goebel, Einat Shacham‐Shmueli, Emilio Bajetta, Martina Makrutzki, Aijing Shang, Thierry André, Paulo M. Hoff - The Lancet Oncology 2012 cited by 526
- A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer
Authors: Michael Proctor, Donald C. McMillan, David Morrison, Colin D. Fletcher, Paul G. Horgan, Stephen Clarke - British Journal of Cancer 2012 cited by 519
- Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study
Authors: Janette L. Vardy, Haryana M. Dhillon, Gregory R. Pond, Sean B. Rourke, Tsegaye Bekele, Corrinne Renton, Anna Dodd, Haibo Zhang, Philip Beale, Stephen Clarke, Ian F. Tannock - Journal of Clinical Oncology 2015 cited by 265
- Activation of Thermogenesis in Brown Adipose Tissue and Dysregulated Lipid Metabolism Associated with Cancer Cachexia in Mice
Authors: Maria Tsoli, Melissa M. Moore, Dominic Burg, Arran Painter, Ryland Taylor, Sarah H. Lockie, Nigel Turner, Alessandra Warren, Greg Cooney, Brian J. Oldfield, Stephen Clarke, Graham Robertson - Cancer Research 2012 cited by 167
- Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer
Authors: Jim Cassidy, Stephen Clarke, Eduardo Díaz‐Rubio, Werner Scheithauer, Arié Figer, Ralph Wong, Sheryl Koski, Mikhail Lichinitser, Tsai‐Shen Yang, Fernando Rivera, Félix Couture, Florin Sirzén, Leonard B. Saltz - Journal of Clinical Oncology 2008 cited by 864
- The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?
Authors: Byeongsang Oh, Frances Boyle, Nick Pavlakis, Stephen Clarke, Thomas Eade, George Hruby, Gillian Lamoury, Susan Carroll, Marita Morgia, Andrew Kneebone, Mark Stevens, Wen Liu, Brian Corless, Mark P. Molloy, Benjamin Y. Kong, Towia A. Libermann, David S. Rosenthal, Michael Back - Cancers 2021 cited by 62
- Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocells
Authors: Sharon M. Sagnella, Lu Yang, Gemma E. Stubbs, Ebru Boslem, Estefanía Martino‐Echarri, Katarzyna Smolarczyk, Stacey L. Pattison, Natasha Vanegas, Eva St. Clair, Stephen Clarke, John A. Boockvar, Jennifer A. MacDiarmid, Himanshu Brahmbhatt - Cancer Cell 2020 cited by 61
- First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials
Authors: Harpreet Wasan, Peter Gibbs, Navesh Sharma, Julien Taı̈eb, Volker Heinemann, Jens Ricke, Marc Peeters, Michael Findlay, Andrew Weaver, Jamie Mills, Charles Wilson, Richard Adams, Anne Francis, Joanna Moschandreas, Pradeep S. Virdee, Peter Dutton, Sharon Love, Val Gebski, Alastair Gray, Richard Adams, Andrew Bateman, Claire Blesing, Ewan Brown, Ian Chau, Sebastian Cummins, David Cunningham, Stephen Falk, Maher Hadaki, Marcia Hall, Tamas Hickish, Joanne Hornbuckle, F. Lofts, Sarah Lowndes, Astrid Mayer, Matthew S. Metcalfe, Gary Middleton, Jamie Mills, Amir Montazeri, R. Muirhead, Andreas Polychronis, Colin Purcell, Paul J. Ross, Ricky A. Sharma, Liz Sherwin, David Smith, Rubin Soomal, Daniel Swinson, Axel Walther, Harpreet Wasan, Andrew Weaver, Charles Wilson, Greg Wilson, Pradip Amin, Bruna Angelelli, Jacques Balosso, Alex Beny, Daniel Bloomgarden, Evelyn Boucher, Michael D. Brown, Harald-Robert Bruch, James Bui, Matthew Burge, Giuseppe Cardaci, James Carlisle, Seungjean Chai, Yi‐Jen Chen, P. Chevallier, Michael Chuong, Stephen Clarke, Andrew L. Coveler, M Craninx, Thierry Delanoit, Amélie Deleporte, Paul Eliadis, Francis Facchini, Thomas W. Ferguson, Michel Ferrante, Michael Findlay, Gary Frenette, Jacob Frick, Vinod Ganju, Michael Garofalo, Karen Geboes, Gerald Gehbauer, Benjamin George, Ravit Geva, Peter Gibbs, Melita A. Gordon, Kate Gregory, Seza A. Güleç, James Hannigan, Guy van Hazel, Norman Heching, Volker Heinemann, Thomas Helmberger, Alain Hendlisz, Koen Hendrickx, Matthew P. Holtzman, Richard Isaacs, Christopher Jackson and 156 more - The Lancet Oncology 2017 cited by 398
- Cancer Patient Disclosure and Patient-Doctor Communication of Complementary and Alternative Medicine Use: A Systematic Review
Authors: Esther Davis, Byeongsang Oh, Phyllis Butow, Barbara Mullan, Stephen Clarke - The Oncologist 2012 cited by 348
- Oxidative stress in prostate cancer patients: A systematic review of case control studies
Authors: Byeongsang Oh, Gemma A. Figtree, Daniel Costa, Thomas Eade, George Hruby, Stephanie Lim, Aymen Elfiky, Neil Martine, David I. Rosenthal, Stephen Clarke, Michael Back - Prostate International 2016 cited by 101
- Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical Review
Authors: Byeongsang Oh, Frances Boyle, Nick Pavlakis, Stephen Clarke, Alex Guminski, Thomas Eade, Gillian Lamoury, Susan Carroll, Marita Morgia, Andrew Kneebone, George Hruby, Mark Stevens, Ryan Wen Liu, Brian Corless, Mark P. Molloy, Towia A. Libermann, David S. Rosenthal, Michael Back - Frontiers in Oncology 2021 cited by 60
- The Cambridge Handbook of Information and Computer Ethics
Authors: Luciano Floridi, Luciano Floridi, Luciano Floridi, Luciano Floridi, Terrell Ward Bynum, Philip Brey, Jeroen van den Hoven, Luciano Floridi, Bernd Carsten Stahl, John P. Sullins, John Arquilla, Alison Adam, Charles Ess, John Weckert, Vincent Wiegel, Colin Allen, Stephen Clarke, Herman T. Tavani, Luciano Floridi - Cambridge University Press eBooks 2010 cited by 208
